Myocarditis risks from Covid-19 vaccines are still less than the risks from Covid-19
The risk of myocarditis has been found to be roughly 16 times higher in Covid-19 patients than in the uninfected.
By
Country Risk Report Q4 2021 - Professional Services
Latest in
Country Risk Report Q4 2021 - Professional Services
Q&A: Covid-19’s Delta subvariant and the risky winter ahead
Virologist Dr Phillip Gould discusses the Delta subvariant, vaccines, and the new Covid-19 antiviral molnupiravir.
By
Supply chain bottlenecks and shortages riskier than Covid-19 – leading macroeconomic influencers
Supply chain disruptions and high inflation likely to last until 2022 in the US.
AstraZeneca vaccine and blood clots: the risks explained
Health authorities in the UK and Europe have confirmed a possible link between the AstraZeneca Covid-19 vaccine and a small…
By
Risk assessment of Covid-19 on patients suffering from IBD
With the growing prevalence of Covid-19 globally it is very important that the health of patient groups suffering from other…
By